This material is intended for UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the ...
This World Diabetes Day, Sanofi UK and DigiBete are hosting a pop-up event in Leeds today and tomorrow, 14th & 15th November, ...
Type 1 diabetes, in which the immune system destroys the insulin -producing cells in the pancreas, often develops more ...
A breakthrough in Type 1 diabetes treatment shows promise. Scientists in Sweden have successfully transplanted gene-edited ...
In young children with type 1 diabetes, nearly all insulin-producing cells are destroyed before they can mature, helping ...
Scientists have discovered why type 1 diabetes is more severe and aggressive when it develops in young children. Type 1 is caused by the immune system attacking cells in the pancreas that control ...
There were no significant differences in the risk of ambulatory care—sensitive condition hospitalization or mortality between patients who initiated analogue insulin compared with the neutral ...
STOCKHOLM, Sweden — Whether "insulin-free type 2 diabetes" is either "coming" or "nonsense" was the topic of a debate at the recent European Association for the Study of Diabetes 2022 Annual Meeting.
The cohort included 22,395 women who received insulin treatment, with 321 incident breast cancer events occurring during up to 12 years of follow-up (incidence rate 3.3 per 1,000 person-years).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback